Françoise Van Bambeke
Citata da
Citata da
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
N Mesaros, P Nordmann, P Plésiat, M Roussel-Delvallez, J Van Eldere, ...
Clinical microbiology and infection 13 (6), 560-578, 2007
Antibiotic efflux pumps
F Van Bambeke, E Balzi, PM Tulkens
Biochemical pharmacology 60 (4), 457-470, 2000
Quinolones in 2005: an update
F Van Bambeke, JM Michot, J Van Eldere, PM Tulkens
Clinical Microbiology and infection 11 (4), 256-280, 2005
Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages
M Barcia-Macay, C Seral, MP Mingeot-Leclercq, PM Tulkens, ...
Antimicrobial Agents and Chemotherapy 50 (3), 841-851, 2006
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy
F Van Bambeke, Y Glupczynski, P Plesiat, JC Pechere, PM Tulkens
Journal of Antimicrobial Chemotherapy 51 (5), 1055-1065, 2003
Glycopeptide antibiotics
F Van Bambeke, Y Van Laethem, P Courvalin, PM Tulkens
Drugs 64 (9), 913-936, 2004
Intracellular pharmacodynamics of antibiotics
S Carryn, H Chanteux, C Seral, MP Mingeot-Leclercq, F Van Bambeke, ...
Infectious Disease Clinics 17 (3), 615-634, 2003
Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux
F Van Bambeke, VJ Lee
Recent patents on anti-infective drug discovery 1 (2), 157-175, 2006
ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions
B Marquez, F Van Bambeke
Current drug targets 12 (5), 600-620, 2011
Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria
H Servais, P Van Der Smissen, G Thirion, G Van der Essen, ...
Toxicology and applied pharmacology 206 (3), 321-333, 2005
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus …
C Seral, F Van Bambeke, PM Tulkens
Antimicrobial agents and chemotherapy 47 (7), 2283-2292, 2003
Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives
F Van Bambeke, M Barcia-Macay, S Lemaire, PM Tulkens
Current Opinion in Drug Discovery and Development 9 (2), 218, 2006
Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against …
S Lemaire, PM Tulkens, F Van Bambeke
Antimicrobial agents and chemotherapy 55 (2), 649-658, 2011
The bacterial envelope as a target for novel anti-MRSA antibiotics
F Van Bambeke, MP Mingeot-Leclercq, MJ Struelens, PM Tulkens
Trends in pharmacological sciences 29 (3), 124-134, 2008
Comparative intracellular (THP-1 macrophage) and extracellular activities of β-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at …
S Carryn, F Van Bambeke, MP Mingeot-Leclercq, PM Tulkens
Antimicrobial Agents and Chemotherapy 46 (7), 2095-2103, 2002
Glycopeptides in clinical development: pharmacological profile and clinical perspectives
F Van Bambeke
Current opinion in pharmacology 4 (5), 471-478, 2004
Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data
LG Garcia, S Lemaire, BC Kahl, K Becker, RA Proctor, O Denis, ...
Journal of antimicrobial chemotherapy 68 (7), 1455-1464, 2013
Safety profile of the respiratory fluoroquinolone moxifloxacin
F Van Bambeke, PM Tulkens
Drug safety 32 (5), 359-378, 2009
Multidrug-resistant Streptococcus pneumoniae infections
F Van Bambeke, RR Reinert, PC Appelbaum, PM Tulkens, ...
Drugs 67 (16), 2355-2382, 2007
Macrolides: pharmacokinetics and pharmacodynamics
F Van Bambeke, PM Tulkens
International journal of antimicrobial agents 18, 17-23, 2001
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20